V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. ...
Imaging live cells with fluorescent proteins has long been a crucial technique for understanding cellular behavior. While bioluminescent proteins offer ...
bit.bio, the global leader in cell programming technology, today announced the successful closing of a $30 million financing round led ...
Asynt report that the Cresswell Group, led by Dr Alexander J. Cresswell at the University of Bath (UK), have demonstrated the synthesis of novel spirocyclic tetrahydonaphthyridines (THNs) expanding the ...
Newcells Biotech (“Newcells”), a leading drug discovery partner specializing in the development of in vitro models and bespoke assay services to improve ...
Researchers at Columbia University Mailman School of Public Health have developed a novel computational pipeline designed to identify protein biomarkers ...
High-Throughput Platform Reduces Manual Steps by up to 90%. Image Credit: Beckman Coulter Life Sciences Beckman Coulter Life Sciences, a ...
Ijeoma Uchegbu, Professor of Pharmaceutical Nanoscience at UCL and Co-Founder and CSO of Nanomerics, gave one of this year's keynote presentations at ...
In this interview from SfN 2024, Professor Nancy Ip, President of The Hong Kong University of Science and Technology, shares ...
The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor ...
